US government threatens Novo Nordisk with fine for discount program violations

The Danish pharmaceutical company, among others, is in non-compliance with US law and thus risks penalty, say US health authorities.
Photo: Novo Nordisk Pharmatech/PR
Photo: Novo Nordisk Pharmatech/PR
BY MATHIAS JULIUS FALKENGAARD, TRANSLATED BY DANIEL PEDERSEN

Novo Nordisk and five other pharmaceutical companies have sued the US government – they argue the US discount system is poorly implemented in several US hospitals, driving uppatient costs.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading